Navigation Links
Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
Date:9/6/2007

presented during a poster presentation on September 26.

The following poster presentation will take place:

Glufosfamide (GLU) plus gemcitabine (GEM) in pancreatic adenocarcinoma: Results of a Phase 2 trial.

Gastrointestinal malignancies -- noncolorectal cancer, Level 0 Wednesday, September 26, 2007 from 9:00am to 12:00pm

A copy of the Phase 3 abstract will be available on the Threshold website on September 27. A copy of the Phase 2 poster and abstract will be available on the website on September 26 at http://investor.thresholdpharm.com/calendar.cfm.

About Threshold Pharmaceuticals

Threshold is a biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer. By selectively targeting abnormally-proliferating tumor cells, the Company's drug candidates are designed to be potentially more effective and less toxic to healthy tissues than conventional treatments. For additional

information, please visit our website (http://www.thresholdpharm.com).

Forward-Looking Statements

Except for statements of historical fact, the statements in this press release are forward-looking statements, including statements regarding Threshold's product candidates, and potential therapeutic uses and benefits of our product candidates. These statements involve risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties include, but are not limited to, Threshold's ability to commence its anticipated clinical trials, the time and expense required to conduct such clinical trials and analyze data, issues arising in the regulatory or manufacturing process and the results of such clinical trials (including product safety issues and efficacy results). F
'/>"/>

SOURCE Threshold Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Threshold Pharmaceuticals Announces Multiple Presentations on Oncology Pipeline at the 2007 American Association for Cancer Research (AACR) Annual Meeting
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 2015 Uroplasty, Inc. (NASDAQ:  UPI) and Vision-Sciences, ... their merger. The merger was originally announced in ... creates a new medical device company named Cogentix ... Medical, Inc. will trade on the NASDAQ under ... U.S. headquarters in Minnetonka, MN ...
(Date:3/31/2015)... LONDON , March 31, 2015 /PRNewswire/ ... drug discovery applications have driven the need ... far the automated segments are going to ... this research. This study provides the market ... profiling and key trends for the liquid ...
(Date:3/31/2015)... Fla. , March 31, 2015 ... strategy and management consulting firm, has launched the ... to enable health IT vendors, payers and pharmacies ... the electronic prior authorization (ePA) of prescription medications. ... authorization (PA) requests are completed through time-consuming, manual ...
Breaking Medicine Technology:Uroplasty and Vision-Sciences Complete Merger 2Uroplasty and Vision-Sciences Complete Merger 3Uroplasty and Vision-Sciences Complete Merger 4Western European Liquid Handling Market 2Point-of-Care Partners Launches the ePA State Navigator 2
... clinical phase I trial,AFF001, AFFiRiS GmbH has now recruited ... aims to investigate the tolerability and safety,of an innovative ... now been vaccinated at least once and have so ... four vaccinations,administered at monthly intervals and is due to ...
... MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP ) announced ... evaluating the safety, tolerability and,pharmacokinetics of MAP0004 in ... Current Medical Research and Opinion. MAP Pharmaceuticals is,developing ... a,potential treatment for migraine., The study results, ...
Cached Medicine Technology:AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 2AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4
(Date:3/31/2015)... Dr. Parsa Mohebi, founder of Parsa Mohebi Hair ... the forefront of using beard hair to fill in ... a novelty has now become an absolute option for giving patients ... really do believe that beard to scalp hair transplant can be ... area isn’t as dense as we would like it,” says Dr. ...
(Date:3/31/2015)... CT (PRWEB) March 31, 2015 Calling all ... against Lyme and other tick-borne diseases! The first annual “Lyme ... Cove Island Park in Stamford, CT. The event, hosted by ... (TBDA), will raise funds to support research and education ... event, open to all ages and abilities, will feature 5K ...
(Date:3/31/2015)... 2015 OnChip Devices , a world ... silicon ESD diode chip targeted towards low voltage LED applications. ... Zeners are ideal for protecting circuits by suppressing voltage higher ... handle pulses of up to 350W and 20A, providing protection ... 61000-4-2 standard. These diodes do not exhibit any device ...
(Date:3/31/2015)... Scotch Plains, NJ (PRWEB) March 31, 2015 ... a board certified dermatologist by the American Board ... surgeon. After extensive dermatology research training at the ... Health, Dr. Li completed his internship in internal ... at the University of Pennsylvania in Philadelphia. Dr. ...
(Date:3/31/2015)... Dr. Uzma Parvez is having a busy ... conducted Grand Grounds Presentations at St. Michael’s Medical Center for ... Effects”. The event was attended by a large gathering ... positive feedback from the Grand Rounds. It was said ... in a while. , Ahead, Dr. Parvez has been ...
Breaking Medicine News(10 mins):Health News:Is Beard to Scalp Hair Transplant the Future? 2Health News:Lyme Research Alliance & Tick-Borne Disease Alliance to Kick-Off 1st “Lyme Walk & Run” Event, April 26 2Health News:OnChip Introduces Low Voltage Diodes for High-Brightness LED Protection 2Health News:Dr. Andrew Li of Warren Skin Care Center Is Celebrating 3 Years Recognized as an "NJ Top Doc" 2Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2
... and none other than ‘gen–present’ and ‘gen-next’ can perfectly relate ... waters continue unabated, people are caught in a frenetic pace, ... seeking newer excitement propelled by desires of a ‘picture-postcard’ life ... is unacceptable - a mute submission to the vagaries of ...
... top Australian researchers have predicted what they hope to be ... transform the way patients are treated, within a period of ... have little choice but to take preventive action when faced ... John Shine, the executive director of the Garvan Institute of ...
... and Locker, Inc. conducted a voluntary recall of over 5,000 ... to alert consumers //of probable beef contamination that was processed ... President Jim Goeser said, "We should note that we have ... certified lab but the voluntary recall must proceed." ,It ...
... Pittsburgh by a team of scientists to study the people aged ... of their long life and to develop tactics to conquer the ... people. ,"The longer we wait, the more they're going ... Coles, the foundation's treasurer and a researcher who has studied the ...
... first death caused by dengue fever in Andhra Pradesh. ... of the state. ,Venkateswara Rao, director (medical ... Puttaparthi in Anantapur district. Two cases in Hyderabad, one ... dengue cases. ,Unofficial reports from different parts ...
... mental fog and forgetfulness and can no longer explain it ... new UCLA study shows that chemotherapy causes changes to the ... 10 years after treatment. Reported Oct. 5 in the online ... findings may help to explain the disrupted thought processes and ...
Cached Medicine News:Health News:Mental Health: Mind at Peace or in Pieces? 2Health News:Mental Health: Mind at Peace or in Pieces? 3Health News:Mental Health: Mind at Peace or in Pieces? 4Health News:Genetics to bring about Medical Breakthroughs 2Health News:Precautionary Recall of Beef over E.coli Contamination Concerns 2Health News:Supercentenarian Center to study longevity 2Health News:First confirmed Dengue death in Andhra Pradesh 2Health News:Chemotherapy's Effects on the Brain 2Health News:Chemotherapy's Effects on the Brain 3
... semiconductor-based laser system representing the latest in technological ... for fast treatment of large areas (14 mm ... High power and large spot size optimize laser ... indicated for the treatment of vascular and pigmented ...
... hands-free automatic alignment system, enabling any member ... IOP measurement in seconds. , ,The operator ... or right and invites the patient to ... pad. The AT555 automatically detects which eye ...
... only portable 36/70 static/kinetic/multi-color perimeter that delivers ... and costs only slightly more than the ... Centerfield automatically performs static and kinetic perimetry ... 70 with a fixation shift. Offers white ...
... new Topcon KR-9000PW Wavefront Analyzer provides ... and complete visual analysis system on ... a full range auto refractometer, auto ... while adding the benefits of wavefront ...
Medicine Products: